Ketorolac (Toradol) Use During Breastfeeding for a 7-Month-Old Infant
Ketorolac is compatible with breastfeeding a 7-month-old infant, as it transfers into breast milk in very low amounts with no demonstrable adverse effects in the infant. 1
Safety Profile of Ketorolac During Breastfeeding
Evidence on Ketorolac Transfer into Breast Milk
- Research has shown that ketorolac transfers into breast milk in minimal amounts:
Age Considerations
- At 7 months of age, an infant has more mature hepatic and renal function compared to neonates, making them less vulnerable to potential medication effects
- The Association of Anaesthetists guideline specifically notes that infants less than 6 weeks of age require extra caution with medications, but your 7-month-old is well beyond this threshold 1
Clinical Recommendations
Administration Guidelines
- Use the lowest effective dose for the shortest duration possible
- No need to "pump and dump" or interrupt breastfeeding when using ketorolac 1
- For postoperative pain, ketorolac can be used as part of a multimodal pain management approach 1, 4
Monitoring
- Although adverse effects are unlikely, observe the infant for any unusual symptoms
- If you notice any changes in the infant's behavior, feeding patterns, or alertness, contact a healthcare provider
Alternative Pain Management Options
If you have concerns about using ketorolac, other NSAIDs that are also considered safe during breastfeeding include:
- Ibuprofen: Has been used extensively during lactation and is considered safe 1
- Diclofenac: Small amounts detected in breast milk; considered safe during breastfeeding 1
- Naproxen: Although it has a longer half-life than diclofenac, it is widely used and considered safe 1
Important Considerations
- The benefits of adequate pain control for the breastfeeding mother often outweigh the minimal risks to the infant
- Untreated pain can interfere with successful breastfeeding by affecting milk letdown reflex and comfortable positioning 4
- For surgical pain, using non-opioid analgesics like ketorolac can help minimize the need for opioids, which may have more significant effects on the infant 1, 4
In conclusion, current evidence supports that ketorolac is a safe option for a breastfeeding mother with a 7-month-old infant, with minimal transfer into breast milk and no reported adverse effects in nursing infants.